Cargando…
Comprehensive characterization of PTEN mutational profile in a series of 34,129 colorectal cancers
Loss of expression or activity of the tumor suppressor PTEN acts similarly to an activating mutation in the oncogene PIK3CA in elevating intracellular levels of phosphatidylinositol (3,4,5)-trisphosphate (PIP3), inducing signaling by AKT and other pro-tumorigenic signaling proteins. Here, we analyze...
Autores principales: | Serebriiskii, Ilya G., Pavlov, Valery, Tricarico, Rossella, Andrianov, Grigorii, Nicolas, Emmanuelle, Parker, Mitchell I., Newberg, Justin, Frampton, Garrett, Meyer, Joshua E., Golemis, Erica A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956741/ https://www.ncbi.nlm.nih.gov/pubmed/35338148 http://dx.doi.org/10.1038/s41467-022-29227-2 |
Ejemplares similares
-
Source, co-occurrence, and prognostic value of PTEN mutations or loss in colorectal cancer
por: Serebriiskii, Ilya G., et al.
Publicado: (2023) -
Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients
por: Serebriiskii, Ilya G., et al.
Publicado: (2019) -
Identification of evolutionarily conserved DNA damage response genes that alter sensitivity to cisplatin
por: Gaponova, Anna V., et al.
Publicado: (2016) -
A gene expression system offering multiple levels of regulation: the Dual Drug Control (DDC) system
por: Sudomoina, Marina, et al.
Publicado: (2004) -
Delineating the RAS Conformational Landscape
por: Parker, Mitchell I., et al.
Publicado: (2022)